Cardiff Oncology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.00
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.26
|
-0.20
|
0.06
|
23.08%
|
|
2022-06-30
|
-0.25
|
-0.24
|
0.01
|
4.00%
|
|
2022-03-31
|
-0.23
|
-0.25
|
-0.02
|
-8.70%
|
|
2021-12-31
|
-0.17
|
-0.23
|
-0.06
|
-35.29%
|
|
2021-09-30
|
-0.17
|
-0.17
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.15
|
-0.17
|
-0.02
|
-13.33%
|
|
2021-03-31
|
-0.15
|
-0.14
|
0.01
|
6.67%
|
|
2020-12-31
|
-0.14
|
-0.19
|
-0.05
|
-35.71%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.69
|
|
2021-12-31
|
-0.71
|
|
2020-12-31
|
-1.30
|
|
2019-12-31
|
-3.03
|
|
2018-12-31
|
-13.93
|
|
2017-12-31
|
-54.72
|
|
2016-12-31
|
-26.51
|
|
2015-12-31
|
-1.09
|
|
2014-12-31
|
-17.09
|
|
2013-12-31
|
-39.60
|
|
2012-12-31
|
-38.69
|
|
2011-12-31
|
-28.02
|